Article Versions Notes

Yuan X, Wang Z, Qiu P, Tong Z, Wang B, Sun Y, Sun X, Sui L, Jia H, Wang J, et al. In Situ Targeting RGD-Modified Cyclodextrin Inclusion Complex/Hydrogel Hybrid System for Enhanced Glioblastoma Therapy. Pharmaceutics. 2025; 17(7):938. https://doi.org/10.3390/pharmaceutics17070938

Yuan, Xiaofeng, Zhenhua Wang, Pengcheng Qiu, Zhenhua Tong, Bingwen Wang, Yingjian Sun, Xue Sun, Lu Sui, Haiqiang Jia, Jiajun Wang, and et al. 2025. "In Situ Targeting RGD-Modified Cyclodextrin Inclusion Complex/Hydrogel Hybrid System for Enhanced Glioblastoma Therapy" Pharmaceutics 17, no. 7: 938. https://doi.org/10.3390/pharmaceutics17070938

Yuan, X., Wang, Z., Qiu, P., Tong, Z., Wang, B., Sun, Y., Sun, X., Sui, L., Jia, H., Wang, J., Tang, H., & Ye, W. (2025). In Situ Targeting RGD-Modified Cyclodextrin Inclusion Complex/Hydrogel Hybrid System for Enhanced Glioblastoma Therapy. Pharmaceutics, 17(7), 938. https://doi.org/10.3390/pharmaceutics17070938